MedDataX Logo

Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

NCT ID: NCT00187967

Last Updated: 2007-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2005-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiopulmonary Bypass Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pumps used for cardiopulmonary bypass

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
* Aspirin therapy

Exclusion Criteria

* Redo surgery
* Acute coronary syndrome requiring urgent surgery
* Oral anticoagulant therapy
* Organ dysfunction or chronic inflammatory disease
* Surgery other than coronary artery bypass grafting
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe Baufreton, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Angers, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Angers

Angers, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anthony Bailleul

Role: CONTACT

Phone: 33-(0)2-41-35-58-91

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christophe Baufreton, MD, PhD

Role: primary

Anthony Bailleul

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PHRC 03-03

Identifier Type: -

Identifier Source: org_study_id